Table 2

Post-Procedural and In-Hospital Outcomes (N = 7)

Procedural results
 Successful device implantation7 (100)
 Conversion to open heart surgery0 (0)
 Device retrieval1 (14)
 Cardiac tamponade0 (0)
 Access site complication1 (14)
 Procedural time, skin to skin, min122 ± 34
 Contrast volume, ml71 ± 32
 Venous closure
 Surgical suture5 (71)
 Percutaneous2 (29)
 Intraprocedural TEE TR reduction >1 grade7 (100)
Hospital outcomes
 Renal failure1 (14)
 Conduction disturbance/arrhythmia2 (29)
 Bleeding (VARC-2 criteria)
 Minor1 (14)
 Major0 (0)
 Vascular or access site complication
 Minor1 (14)
 Major0 (0)
 Pneumonia1 (14)
 Pulmonary embolism0 (0)
 Hospitalization length, days4 (3–6)
 In-hospital mortality0 (0)

Values are n (%), mean ± SD, or median (interquartile range).

TEE = transesophageal echocardiography; TR = tricuspid regurgitation; VARC-2 = Valve Academic Research Consortium-2.

  • With the Perclose Proglide closure system (Abbott Vascular, Santa Clara, California).